wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33615268-AE9326FA-03E1-430F-9BAC-43D736371F60
Q33615268-AE9326FA-03E1-430F-9BAC-43D736371F60
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33615268-AE9326FA-03E1-430F-9BAC-43D736371F60
An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo.
P2860
Q33615268-AE9326FA-03E1-430F-9BAC-43D736371F60
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33615268-AE9326FA-03E1-430F-9BAC-43D736371F60
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a7417f9510d582b62c382f4f2382d96a7f395f7d
P2860
Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial.